S-Ventures PLC The VSA Capital, Aquis Showcase Event (7468G)
17 Noviembre 2022 - 1:00AM
UK Regulatory
TIDMSVEN
RNS Number : 7468G
S-Ventures PLC
17 November 2022
17 November 2022
S-VENTURES PLC
("S-Ventures" or the "Company")
The VSA Capital, Aquis Showcase Event
S-Ventures, the company investing in and growing exciting brands
across the natural, wellness and food-tech category, is pleased to
announce that the Company will be presenting at The VSA Capital,
Aquis Showcase Event on 29 November 2022 at the Royal College of
Surgeons of England, 38-43 Lincoln's Inn Fields, London, WC2A 3PE.
The Company is looking forward to meeting existing and future
shareholders at the event.
20 companies will be presenting during the course of the day and
will be split into 4 groups and given 10 minutes each to pitch
their business case to the audience, who will vote for their
favourites using a QR code. The Company will give a presentation
between 12:00-12:45 on 29 November.
For further information on The VSA Capital Aquis Showcase Event
and to register for tickets, please visit The VSA Capital, Aquis
Showcase Event Tickets, Tue 29 Nov 2022 at 08:00 | Eventbrite
For further information, please contact:
The Company
Robert Hewitt (Chief Financial
Officer)
Scott Livingston (Chief Executive
Officer) +44 (0) 1932 400 224
AQSE Corporate Adviser and
Broker:
VSA Capital Limited
Andrew Raca - Corporate Finance
Andrew Monk - Corporate Broking +44 (0) 20 3005 5000
---------------------
IFC Advisory (Financial PR)
Graham Herring
Tim Metcalfe
Florence Chandler +44 (0) 20 3934 6630
---------------------
About S-Ventures
S-Ventures is listed on UK AQUIS Exchange (Ticker Code "SVEN").
The Company seeks to identify investment opportunities in the
health & wellness, organic food and wellbeing sectors within
the UK and Europe, adding value by providing capital and expertise
to the target companies. The experience and operational skills of
the Board led by Scott Livingston (CEO) are intended to act as an
accelerator to smaller brands that have a solid foundation and
platform but may lack the skills and capital. The main objectives
are to cross-fertilise opportunities between the target companies
and scale the individual entities and look for exit opportunities
and/or synergistic collaborations through scaling we seek to create
significant value for all stakeholders. Since listing on AQSE in
September 2020, the Company has acquired significant interests in
seven companies.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NEXBKOBBABDKCDD
(END) Dow Jones Newswires
November 17, 2022 02:00 ET (07:00 GMT)
SVentures (AQSE:SVEN)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
SVentures (AQSE:SVEN)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024